Literature DB >> 21324513

Prolonged clinical response to trabectedin in a heavily pretreated patient with advanced uterine leiomyosarcoma: a case report and literature review.

Giacomo Corrado1, Vanda Salutari, Gilda Fuoco, Alessandro Lucidi, Gabriella Ferrandina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21324513     DOI： 10.1016/j.ygyno.2011.01.028

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  3 in total

Review 1.  Current Chemotherapy and Potential New Targets in Uterine Leiomyosarcoma.

Authors:  Shabnam Momtahen; John Curtin; Khush Mittal
Journal:  J Clin Med Res       Date:  2016-01-26

2.  Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO).

Authors:  María Jesús Rubio; María José Lecumberri; Silvia Varela; Jesús Alarcón; María Eugenia Ortega; Lydia Gaba; Jaime Espinós; Julia Calzas; Pilar Barretina; Isabel Ruiz; Gloria Marquina; Ana Santaballa
Journal:  Gynecol Oncol Rep       Date:  2020-06-04

3.  Long-Lasting Response to Trabectedin in a Patient with Metastatic Uterine Leiomyosarcoma: A Case Report.

Authors:  Viktoria-Anna Nteli; Wolfgang Knauf; Anja Janton-Klein; Samer El-Safadi
Journal:  Case Rep Oncol       Date:  2018-02-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.